These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 9681249)

  • 1. Adjunctive immunotherapy of tuberculosis.
    Toossi Z
    Cytokines Cell Mol Ther; 1998 Jun; 4(2):105-12. PubMed ID: 9681249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Up-to-date understanding of tuberculosis immunity].
    Mitsuyama M; Akagawa K; Kobayashi K; Sugawara I; Kawakami K; Yamamoto S; Okada Z
    Kekkaku; 2003 Jan; 78(1):51-5. PubMed ID: 12683337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Tuberculosis in compromised hosts].
    Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunotherapeutic potential of recombinant ESAT-6 protein in mouse model of experimental tuberculosis.
    Mir SA; Verma I; Sharma S
    Immunol Lett; 2014; 158(1-2):88-94. PubMed ID: 24345702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunotherapy for MDR-TB (multi-drug resistant tuberculosis)--its feasibility].
    Tsuyuguchi I
    Kekkaku; 1999 Jun; 74(6):479-91. PubMed ID: 10423959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A drug delivery system and biological response modifiers for the treatment of mycobacterial infection].
    Koga H; Miyazaki Y; Kohno S; Hara K
    Kekkaku; 1994 Feb; 69(2):113-8. PubMed ID: 8126987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclophosphamide enhances the antitumor efficacy of adoptively transferred immune cells through the induction of cytokine expression, B-cell and T-cell homeostatic proliferation, and specific tumor infiltration.
    Bracci L; Moschella F; Sestili P; La Sorsa V; Valentini M; Canini I; Baccarini S; Maccari S; Ramoni C; Belardelli F; Proietti E
    Clin Cancer Res; 2007 Jan; 13(2 Pt 1):644-53. PubMed ID: 17255288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Factors for the onset of and the exacerbation of tuberculosis. 2. Host factors promoting the occurrence and exacerbation of tuberculosis: significance of Th1-Th2 cytokine balance].
    Kawakami K
    Kekkaku; 1999 Oct; 74(10):735-40. PubMed ID: 10565134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunodominant PstS1 antigen of mycobacterium tuberculosis is a potent biological response modifier for the treatment of bladder cancer.
    Sänger C; Busche A; Bentien G; Spallek R; Jonas F; Böhle A; Singh M; Brandau S
    BMC Cancer; 2004 Nov; 4():86. PubMed ID: 15566565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokines differentially regulate CXCL10 production by interferon-gamma-stimulated or tumor necrosis factor-alpha-stimulated human gingival fibroblasts.
    Hosokawa Y; Hosokawa I; Ozaki K; Nakae H; Matsuo T
    J Periodontal Res; 2009 Apr; 44(2):225-31. PubMed ID: 18973545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunotherapy with fragmented Mycobacterium tuberculosis cells increases the effectiveness of chemotherapy against a chronical infection in a murine model of tuberculosis.
    Cardona PJ; Amat I; Gordillo S; Arcos V; Guirado E; Díaz J; Vilaplana C; Tapia G; Ausina V
    Vaccine; 2005 Feb; 23(11):1393-8. PubMed ID: 15661388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hematopoietic stem cell graft manipulation as a mechanism of immunotherapy.
    Talmadge JE
    Int Immunopharmacol; 2003 Aug; 3(8):1121-43. PubMed ID: 12860168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination nonviral interleukin-2 gene immunotherapy for head and neck cancer: from bench top to bedside.
    O'Malley BW; Li D; McQuone SJ; Ralston R
    Laryngoscope; 2005 Mar; 115(3):391-404. PubMed ID: 15744147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic effect of DNA vaccines combined with chemotherapy in a latent infection model after aerosol infection of mice with Mycobacterium tuberculosis.
    Ha SJ; Jeon BY; Kim SC; Kim DJ; Song MK; Sung YC; Cho SN
    Gene Ther; 2003 Sep; 10(18):1592-9. PubMed ID: 12907951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beneficial effect of anti-interleukin-4 antibody when administered in a murine model of tuberculosis infection.
    Roy E; Brennan J; Jolles S; Lowrie DB
    Tuberculosis (Edinb); 2008 May; 88(3):197-202. PubMed ID: 18096435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapy of tuberculosis in mice by DNA vaccination.
    Lowrie DB; Tascon RE; Bonato VL; Lima VM; Faccioli LH; Stavropoulos E; Colston MJ; Hewinson RG; Moelling K; Silva CL
    Nature; 1999 Jul; 400(6741):269-71. PubMed ID: 10421369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances in biological therapy for inflammatory bowel disease.
    Kurtovic J; Segal I
    Trop Gastroenterol; 2004; 25(1):9-14. PubMed ID: 15303463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of infection of thermal injury by Pseudomonas aeruginosa PAO1 on the murine cytokine response.
    Rumbaugh KP; Colmer JA; Griswold JA; Hamood AN
    Cytokine; 2001 Nov; 16(4):160-8. PubMed ID: 11792126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.